A Phase 2a Study to Evaluate the Safety and Efficacy of AZX100 in Trocar Sites of Arthroscopic Shoulder Surgery Patients

Completed · Phase 2 · Has a placebo group

Conditions studied: Scar Prevention, Scar Reduction

In brief

The purpose of this study was to determine the safety of AZX100 Drug Product and to determine whether it was effective in preventing or reducing scars that were made from trocars following arthroscopic shoulder surgery.

Key facts

Study ID
NCT00811577
Run by
Capstone Therapeutics
People needed
150
Starts
2009-01-01
Expected to finish
2010-12-01
Last updated by the study team
2012-10-11

Who can join

Age: 18 and older, up to 75. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.